Argentina Develops Cheaper Biosimilar Cancer Drug

Argentina has developed a more affordable biosimilar version of a leading cancer drug, a move attributed to strict patent regulations that are now being observed by pharmaceutical companies and states globally.

25 Apr, 12:18 — 25 Apr, 12:18

Post Share

Sources

Showing 1 of 1 sources

buenos-aires-heraldMostly Factual3h ago

How Argentina created a cheaper version of a top cancer drug. Can others follow?

Strict patent regulations — now loosened by Milei — led to a biosimilar that pharmaceuticals and states are watching with interest La entrada How Argentina created a cheaper version of a top cancer drug. Can others follow? se publicó primero en Buenos Aires Herald.

By Veronica Smink

Read full article →

PERSPECTA

PERSPECTA

Argentina Develops Cheaper Biosimilar Cancer Drug

Sources

How Argentina created a cheaper version of a top cancer drug. Can others follow?

Related Stories

Metro Cebu Air Quality Deteriorates to Unhealthy Levels

Intense heat, power outage strike Samar on Saturday

Scorching Heat Grips Visayas, Philippines

Icelandic Ministry of Health Considers Further Funding for Harm Reduction Organization

PERSPECTA